This user has not added any information to their profile yet.
Founder and Chief Medical Officer
MD
Founder, Officer, Pharmaceutical Company, Clinical Research
Allodynic Therapeutics, LLC
Allodynic Therapeutics is a clinical-stage biopharma company developing naltrexone-acetaminophen (ALLOD-2) for the treatment of acute migraine. Naltrexone-acetaminophen U.S. patents extend to 2037